Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction
- PMID: 22980968
- PMCID: PMC4346027
- DOI: 10.1016/j.amjcard.2012.07.045
Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction
Abstract
Epicardial fat is a metabolically active fat depot that is strongly associated with obesity, metabolic syndrome, and coronary artery disease (CAD). The relation of epicardial fat to diastolic function is unknown. We sought to (1) understand the relation of epicardial fat volume (EFV) to diastolic function and (2) understand the role of EFV in relation to potential risk factors (hypertension, subclinical CAD, and metabolic syndrome) of diastolic dysfunction in apparently healthy subjects with preserved systolic function and no history of CAD. We studied 110 consecutive subjects (65% men, 55 ± 13 years old, mean body mass index 28 ± 5 kg/m(2)) who underwent cardiac computed tomography and transthoracic echocardiography within 6 months as part of a self-referred health screening program. Exclusion criteria included history of CAD, significant valvular disease, systolic dysfunction (left ventricular ejection fraction <50%). Diastolic function was defined according to American Society of Echocardiography guidelines. EFV was measured using validated cardiac computed tomographic software by 2 independent cardiologists blinded to clinical and echocardiographic data. Hypertension and metabolic syndrome were present in 60% and 45%, respectively. Subclinical CAD was identified in 20% of the cohort. Diastolic dysfunction was present in 45 patients. EFV was an independent predictor of diastolic dysfunction, mean peak early diastolic mitral annular velocity, and ratio of early diastolic filling to peak early diastolic mitral annular velocity (p = 0.01, <0.0001, and 0.001, respectively) with incremental contribution to other clinical factors. In conclusion, EFV is an independent predictor of impaired diastolic function in apparently healthy overweight patients even after accounting for associated co-morbidities such as metabolic syndrome, hypertension, and subclinical CAD.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
DISCLOSURES: None of the authors has any conflict of interest related to the content of this paper.
Figures



Similar articles
-
Relation of epicardial fat to central aortic pressure and left ventricular diastolic function in patients with known or suspected coronary artery disease.Int J Cardiovasc Imaging. 2014 Oct;30(7):1393-8. doi: 10.1007/s10554-014-0472-2. Epub 2014 Jun 19. Int J Cardiovasc Imaging. 2014. PMID: 24943993
-
Interrelations of Epicardial Fat Volume, Left Ventricular T1-Relaxation Times and Myocardial Strain in Hypertensive Patients: A Cardiac Magnetic Resonance Study.J Thorac Imaging. 2017 May;32(3):169-175. doi: 10.1097/RTI.0000000000000264. J Thorac Imaging. 2017. PMID: 28419023
-
Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction.Am J Cardiol. 2014 Dec 1;114(11):1663-9. doi: 10.1016/j.amjcard.2014.08.037. Epub 2014 Sep 16. Am J Cardiol. 2014. PMID: 25306552
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
-
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis.Hepatol Int. 2022 Apr;16(2):269-281. doi: 10.1007/s12072-022-10319-6. Epub 2022 Mar 23. Hepatol Int. 2022. PMID: 35320497 Review.
Cited by
-
Development of a nomogram for predicting the risk of left ventricular diastolic function in subjects with type-2 diabetes mellitus.Int J Cardiovasc Imaging. 2022 Jan;38(1):15-23. doi: 10.1007/s10554-021-02338-5. Epub 2021 Nov 16. Int J Cardiovasc Imaging. 2022. PMID: 34783930 Free PMC article.
-
Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis.PLoS One. 2020 Mar 2;15(3):e0229636. doi: 10.1371/journal.pone.0229636. eCollection 2020. PLoS One. 2020. PMID: 32119694 Free PMC article.
-
Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis.Acad Radiol. 2017 Dec;24(12):1473-1481. doi: 10.1016/j.acra.2017.07.003. Epub 2017 Aug 26. Acad Radiol. 2017. PMID: 28847640 Free PMC article.
-
Association among epicardial fat, heart rate recovery and circadian blood pressure variability in patients with hypertension.Clin Hypertens. 2015 Nov 22;21:24. doi: 10.1186/s40885-015-0034-5. eCollection 2015. Clin Hypertens. 2015. PMID: 26893934 Free PMC article.
-
Epicardial Fat Thickness and Neutrophil to Lymphocyte Ratio are Increased in Non-Dipper Hypertensive Patients.J Cardiovasc Ultrasound. 2016 Dec;24(4):294-302. doi: 10.4250/jcu.2016.24.4.294. Epub 2016 Dec 28. J Cardiovasc Ultrasound. 2016. PMID: 28090257 Free PMC article.
References
-
- Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110:3081–3087. - PubMed
-
- Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313. - PubMed
-
- Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O’Donnell CJ, Fox CS. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605–613. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous